Beyond Dual Therapy: Rethinking Tegoprazan–Amoxicillin for H. pylori
- 7 September 2026
- journal article
- letter
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (10) , 3325-3326
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Efficacy and Safety of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled TrialsJournal of Gastroenterology and Hepatology, 2026
- Antibiotic resistance of Helicobacter pylori in Mainland China: A focus on geographic differences through systematic review and meta-analysisInternational Journal of Antimicrobial Agents, 2024
- Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern ItalyAntibiotics, 2022